Boston Scientific (BSX) – ($9.08) has a Buy rating according to ValuEngine with fair value at $9.66, which makes the stock 6.00% undervalued. The one-year price target is $9.52. ValuEngine Profile – “Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company’s products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary medicine, radiology, urology and vascular surgery.”
Analysis – The daily chart for BSX shows overbought momentum with the stock above its 21-day, 50-day and 200-day simple moving averages at $8.37, $7.88 and $6.51. My weekly value level is $8.55 with no risky levels.
Courtesy of Thomson / Reuters
|
Ticker |
Company Name |
Mkt Price |
Fair Value |
One-Year Price Target |
Last 12-Mon Retn (%) |
5-Yr Avg Retn (%) |
P/E Ratio |
|
BSX |
BOSTON SCIENTIFIC |
9.08 |
9.66 |
9.52 |
53.64 |
-11.15 |
13.22 |
Read Next
